MEDI · Harbor Health Care ETF ETF
Harbor ETF Trust
$32.72
+0.88%
At close · Oct 5
Net assets $41,207,807
Holdings44
1 month
-4.80%
Year to date
+4.03%
52-week range
$27.50–$35.61
30-session avg volume
4,612
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000077996
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings59.70%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.61%
Country allocation
US76.66%
DK15.07%
NL2.59%
FR2.53%
KY1.91%
CA0.51%
CH0.33%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | LLY | $8,564,602 | 20.78% |
| Ascendis Pharma A/S | 000000000 | $5,608,223 | 13.61% |
| Gilead Sciences Inc | GILD | $2,100,938 | 5.10% |
| Rhythm Pharmaceuticals Inc | RYTM | $1,655,490 | 4.02% |
| AbbVie Inc | ABBV | $1,274,524 | 3.09% |
| Intuitive Surgical Inc | ISRG | $1,165,989 | 2.83% |
| Cencora Inc | COR | $1,131,410 | 2.75% |
| Revolution Medicines Inc | RVMD | $1,046,980 | 2.54% |
| Insmed Inc | INSM | $1,036,582 | 2.52% |
| Merck & Co Inc | MRK | $1,016,471 | 2.47% |
| Boston Scientific Corp | BSX | $989,087 | 2.40% |
| Natera Inc | NTRA | $930,466 | 2.26% |
| Abivax SA | ABVX | $891,804 | 2.16% |
| Insulet Corp | PODD | $864,119 | 2.10% |
| Argenx SE | ARGX | $854,674 | 2.07% |
| Vaxcyte Inc | PCVX | $848,786 | 2.06% |
| McKesson Corp | MCK | $833,929 | 2.02% |
| Legend Biotech Corp | LEGN | $786,798 | 1.91% |
| Danaher Corp | DHR | $711,092 | 1.73% |
| Guardant Health Inc | GH | $635,811 | 1.54% |
| Novo Nordisk A/S | NVO | $601,682 | 1.46% |
| IDEXX Laboratories Inc | IDXX | $578,078 | 1.40% |
| UnitedHealth Group Inc | UNH | $572,701 | 1.39% |
| PTC Therapeutics Inc | PTCT | $538,163 | 1.31% |
| Vertex Pharmaceuticals Inc | VRTX | $502,386 | 1.22% |
| Alnylam Pharmaceuticals Inc | ALNY | $499,414 | 1.21% |
| Thermo Fisher Scientific Inc | TMO | $479,541 | 1.16% |
| Adaptive Biotechnologies Corp | ADPT | $402,987 | 0.98% |
| Madrigal Pharmaceuticals Inc | MDGL | $381,800 | 0.93% |
| Praxis Precision Medicines Inc | PRAX | $375,860 | 0.91% |
| Dexcom Inc | DXCM | $332,048 | 0.81% |
| RadNet Inc | RDNT | $328,212 | 0.80% |
| Penumbra Inc | PEN | $317,015 | 0.77% |
| Relay Therapeutics Inc | RLAY | $264,354 | 0.64% |
| Oruka Therapeutics Inc | ORKA | $245,714 | 0.60% |
| IRhythm Holdings Inc | IRTC | $237,269 | 0.58% |
| Viatris Inc | VTRS | $235,725 | 0.57% |
| Newamsterdam Pharma Co NV | 000000000 | $212,760 | 0.52% |
| Xenon Pharmaceuticals Inc | XENE | $210,697 | 0.51% |
| Indivior Pharmaceuticals Inc | INDV | $205,811 | 0.50% |
| Axsome Therapeutics Inc | AXSM | $202,513 | 0.49% |
| Inventiva SACA | IVA | $152,302 | 0.37% |
| Sophia Genetics SA | 000000000 | $137,594 | 0.33% |
| Ionis Pharmaceuticals Inc | IONS | $84,437 | 0.20% |